Planoptik's capacity ramp sets up a strong 2027, though it is not an AI story. Order intake rose 145% as it ramps wafer production at cleanrooms in Hungary and Germany, and management expects new customers' series ramps to lift revenue significantly from 2027. Revenue grew 5.7% and EBITDA 8.9%, at about 22x LTM EV/EBITDA, with FY26 guidance below 10% growth. Heavy capex should now show in revenue and margins. The new customers are in microfluidics, with no evidence of an optical-switch benefit. x.com x.com
